Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNO 1016 for acute rhinosinusitis in adults
2009-016682-28Phase 3Completed
- Sponsor
- Bionorica
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing BNO 1016 with Placebo (2 arms). Primary endpoints: Major Symptom Score at Day 14 and Safety of BNO 1016. Started Nov 2009; status: completed.
02
Drugs
Sinupret extract
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2009-016682-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016682-28.